You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

56 Results
Statistical Reports
Sep 2016
Statistical Reports
Jun 2016
Regimen
Cancer Type:
Gynecologic, 
Cervix
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Pembrolizumab - Metastatic, Persistent, or Recurrent Carcinoma of the Cervix
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
pembrolizumab,
PACLitaxel,
CARBOplatin
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jun 2023
Guidelines and Advice
Status: Current
ID: PET 2022-2
Jun 2023
Guidelines and Advice
Status: Current
ID: GL END 5-13
Version: N/A
Jun 2023
Guidelines and Advice
Status: In-Review
ID: 24-3
Version: 2
Dec 2016
Guidelines and Advice
Status: Archived
ID: 17-4
Version: 2
Nov 2016
Guidelines and Advice
Status: Archived
ID: SCT 6
Feb 2016

Pages